With her recent
groundbreaking findings in the field of RNA - mediated regulation based on the CRISPR - Cas9 system, E. Charpentier has laid the foundation for the development of a novel, highly versatile and specific genome
editing technology that is revolutionizing life sciences research and could open up whole new opportunities in biomedical
gene therapies.